Skip to content

Drug interactions

Salmeterol + Tucatinib

Severity: Moderate

Salmeterol and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib is a moderate CYP3A inhibitor and may raise salmeterol exposure. This can increase beta-agonist adverse effects such as tachycardia, tremor and QT prolongation.

What this interaction means in plain words

Salmeterol and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Salmeterol belongs to Respiratory; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

CYP3A4 inhibition by tucatinib reduces salmeterol clearance.

What to do

Monitor heart rate, palpitations and potassium, and consider an alternative bronchodilator if symptoms emerge. Obtain an ECG in patients with cardiac risk factors.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Salmeterol and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Salmeterol with Tucatinib?

MediHelp rates the interaction as moderate. Salmeterol and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib is a moderate CYP3A inhibitor and may raise salmeterol exposure. This can increase beta-agonist adverse effects such as tachycardia, tremor and QT prolongation.

How serious is the interaction between Salmeterol and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate, palpitations and potassium, and consider an alternative bronchodilator if symptoms emerge. Obtain an ECG in patients with cardiac risk factors.

What other medicines interact with Salmeterol?

MediHelp also lists interactions of Salmeterol with, for example, Ritonavir, Saquinavir, Amitriptyline. The full list is on the Salmeterol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in